Common Lab Markers for Liver and Kidney Health Explained

Blood and urine tests can reveal signs of liver injury, impaired bile flow, reduced kidney filtration, protein leakage, and changes in the body’s fluid or mineral balance. However, no single result can provide a complete diagnosis. A mildly abnormal enzyme may be temporary, while significant disease can sometimes be present even when commonly measured values remain within the laboratory’s reference range.

The most useful interpretation comes from looking at patterns: which markers changed, how far they changed, whether the abnormality persists, and how the results compare with previous testing. Symptoms, medications, supplements, alcohol exposure, hydration, recent illness, physical activity, metabolic health, and imaging findings may all affect what a result means.

For an overview of how these organs normally process substances and maintain the body’s internal balance, see Liver and Kidney Health: How the Body Filters, Balances, and Protects Itself.

What Lab Tests Can—and Cannot—Tell You

A laboratory marker is a measurable substance that provides information about a biological process. It may reflect cell injury, waste accumulation, filtration, inflammation, bile flow, protein production, mineral balance, or another aspect of organ health.

A marker is not automatically a diagnosis. An elevated liver enzyme does not identify the cause of liver injury by itself, and an isolated creatinine result does not fully describe kidney health. Clinicians combine laboratory findings with medical history, physical examination, medication use, risk factors, and sometimes imaging or biopsy. NIDDK notes that liver and kidney diagnoses commonly depend on combinations of tests rather than one result alone.

Laboratory reference ranges are also not universal. They can differ because of the test method, laboratory equipment, population used to establish the range, age, sex, pregnancy status, and other factors. Results should therefore be interpreted against the range printed on the individual report rather than compared with a random range found elsewhere. MedlinePlus emphasizes that normal ranges can vary by laboratory and patient characteristics.

Quick Overview of Common Markers

Marker	Sample	What it mainly reflects	Important limitation
ALT	Blood	Injury or irritation involving liver cells	Does not identify the cause or measure total liver function
AST	Blood	Liver-cell injury, interpreted with ALT and other findings	Also occurs in muscle and other tissues
ALP	Blood	Possible bile-duct or cholestatic pattern	Can also rise because of bone-related conditions
GGT	Blood	Helps clarify whether an ALP elevation may come from the liver or bile system	Can rise for several reasons and is not diagnostic alone
Bilirubin	Blood or urine	Processing and excretion of a blood-cell breakdown product	May rise from liver, bile-duct, or blood-related causes
Albumin	Blood	Protein made by the liver; also affected by nutrition, inflammation, and protein loss	A low level is not specific to liver disease
PT/INR	Blood	Time required for blood to clot; may reflect production of clotting factors	Strongly affected by warfarin and other non-liver factors
Creatinine	Blood	Waste marker used to estimate kidney filtration	Affected by muscle mass, diet, medicines, and acute illness
eGFR	Calculated from blood testing	Estimated rate of kidney filtration	It is an estimate and should be interpreted over time
UACR	Urine	Albumin leakage through the kidney’s filtering barrier	Temporary factors can raise it, so confirmation may be needed
BUN	Blood	Amount of urea nitrogen in circulation	Influenced by hydration, protein intake, bleeding, and tissue breakdown
Urinalysis	Urine	Protein, blood, glucose, cells, infection-related findings, and crystals	Abnormalities may come from anywhere in the urinary tract

The table provides a practical orientation rather than a diagnostic formula. The clinical meaning of each marker depends heavily on the other results around it.

Understanding Common Liver Lab Markers

A group of liver-related measurements may be called a liver panel, hepatic function panel, liver chemistry panel, or liver function tests. These terms are often used interchangeably, although not every component directly measures function.

ALT, AST, ALP, and GGT are enzymes. They primarily provide information about cell injury or bile-flow patterns. Albumin and PT/INR are more closely related to the liver’s ability to produce proteins, although they can also change for reasons unrelated to liver disease. Bilirubin reflects how the body processes and eliminates a product formed during normal red-blood-cell breakdown.

Alanine Aminotransferase: ALT

ALT is an enzyme found mainly in the liver. When liver cells are injured or inflamed, ALT may enter the bloodstream and rise above the laboratory’s reference range. It is commonly included in routine metabolic panels and is used to help detect or monitor liver injury.

An elevated ALT may occur with:

• Metabolic dysfunction-associated steatotic liver disease
• Viral hepatitis
• Medication- or supplement-related liver injury
• Alcohol-associated liver disease
• Autoimmune hepatitis
• Reduced blood flow to the liver
• Other acute or chronic liver conditions

The degree of elevation does not reliably show how much permanent scarring is present. A high ALT can occur during acute inflammation without advanced fibrosis, while someone with cirrhosis may have only a mild elevation or even an ALT within the laboratory range.

ALT can also fluctuate. Recent illness, medication changes, weight changes, and metabolic health may affect the result. Persistent abnormalities generally carry more meaning than a single mild elevation.

Aspartate Aminotransferase: AST

AST is another enzyme that may rise when liver cells are damaged. Unlike ALT, AST is also present in skeletal muscle, heart tissue, and other parts of the body. An elevated AST is therefore less liver-specific and should be interpreted alongside ALT, ALP, bilirubin, symptoms, and relevant history.

Strenuous exercise, muscle injury, and certain muscle disorders can raise AST. When AST is elevated without a similar ALT change, clinicians may consider whether the source is outside the liver.

The relationship between AST and ALT may sometimes contribute to pattern recognition, but the ratio does not diagnose a condition by itself. Alcohol use, disease stage, muscle health, medications, and timing can all influence the relationship.

Why ALT and AST Are Not Complete “Function” Tests

ALT and AST mainly indicate injury or cellular leakage. They do not directly show how effectively the liver is producing albumin, making clotting proteins, moving bile, or performing every metabolic task.

A person can have elevated enzymes while the liver continues performing its essential functions. Conversely, advanced chronic liver disease can sometimes exist without dramatic enzyme elevations. This is why clinicians may also examine bilirubin, albumin, PT/INR, platelet count, imaging, and fibrosis assessments. NIDDK describes liver evaluation as a combination of enzymes, proteins, bilirubin, blood counts, imaging, and other testing.

Alkaline Phosphatase: ALP

ALP is an enzyme found in several tissues, especially the liver’s bile-duct system and bone. A high ALP result may suggest impaired bile flow, bile-duct inflammation, or obstruction, but it may also result from increased bone activity or a bone-related condition.

Possible liver or bile-related explanations include:

• Gallstones blocking a bile duct
• Inflammation or narrowing of the bile ducts
• Medication-related cholestasis
• Primary biliary cholangitis
• Primary sclerosing cholangitis
• A mass affecting bile drainage
• Infiltrative liver disease

ALP may also be higher during periods of bone growth, fracture healing, pregnancy, or certain bone disorders. Because ALP is not liver-specific, another marker—often GGT—may help determine whether the elevation is more likely to have come from the hepatobiliary system.

Gamma-Glutamyl Transferase: GGT

GGT is an enzyme found largely in the liver and bile system. It is commonly interpreted with ALP. When both GGT and ALP are elevated, a liver or bile-duct source becomes more likely than a bone source. When ALP is high but GGT is not, clinicians may look more closely at bone-related explanations.

GGT may also rise with alcohol exposure and certain medicines, but it is not specific enough to establish alcohol-associated liver disease. Medical history and the rest of the liver panel remain essential. MedlinePlus advises that GGT results be interpreted with symptoms, history, and other blood tests.

Bilirubin

Bilirubin is produced when the body breaks down aging red blood cells. The liver takes up bilirubin, processes it, and helps move it into bile for elimination through the digestive tract.

A blood report may include:

• Total bilirubin: The combined amount of bilirubin in the blood
• Direct bilirubin: Bilirubin that has been processed into a water-soluble form
• Indirect bilirubin: The portion that has not yet been conjugated by the liver

The direct and indirect pattern can help narrow the possibilities, but it is not diagnostic on its own.

Elevated bilirubin may result from:

• Increased breakdown of red blood cells
• Reduced bilirubin processing
• Liver-cell injury
• Impaired bile flow
• Gallstones or another bile-duct obstruction
• Certain inherited conditions

Higher bilirubin can cause yellowing of the skin or eyes, called jaundice. Dark urine and pale stools may occur when bilirubin handling or bile flow is disrupted. NIDDK lists elevated bilirubin and jaundice among findings that may accompany liver disease.

A mild isolated bilirubin elevation does not always indicate serious liver damage. Some inherited conditions alter bilirubin processing without causing progressive liver disease. The other liver markers and the direct-versus-indirect pattern help guide interpretation.

Albumin

Albumin is a protein made by the liver. It helps maintain fluid within the circulation and transports hormones, vitamins, medicines, and other substances.

A low serum albumin level can occur when:

• The liver is not producing enough albumin
• The kidneys are allowing albumin to leak into the urine
• Protein is being lost through the digestive tract or damaged skin
• Nutritional intake or absorption is inadequate
• Inflammation changes albumin production and distribution
• Fluid overload dilutes the measured concentration

Albumin often changes more gradually than ALT or AST because it remains in circulation for an extended period. A low result may therefore be more consistent with a chronic process than a brief episode of mild liver irritation, but it is not specific enough to identify the cause.

A high albumin result more commonly reflects reduced blood-water volume, such as dehydration, rather than excess liver production. MedlinePlus notes that low albumin can accompany liver, kidney, and other conditions, while high albumin may occur with dehydration.

Prothrombin Time and INR

Prothrombin time measures how many seconds it takes a blood sample to form a clot. The international normalized ratio, or INR, standardizes the result so it can be compared more consistently across laboratories and testing methods.

The liver produces many clotting factors. When production is significantly impaired, PT may become longer and INR may rise. This can occur in advanced chronic liver disease or severe acute liver injury.

However, PT/INR is affected by several other factors, including:

• Warfarin treatment
• Vitamin K deficiency
• Poor absorption of fat-soluble vitamins
• Certain clotting disorders
• Massive transfusion
• Laboratory and specimen-related issues

An elevated INR is interpreted very differently in someone taking warfarin than in someone who is not using an anticoagulant. Medication context is essential.

Total Protein, Globulins, and the A/G Ratio

Total protein measures albumin plus several other blood proteins, including globulins. The albumin-to-globulin ratio compares these two broad groups.

Abnormal total protein or globulin results may occur with liver disease, kidney disease, inflammation, infection, immune-system disorders, nutritional problems, or certain blood conditions. These measurements provide context but are rarely specific enough to establish a liver diagnosis alone.

Platelet Count and Liver Health

Platelets are blood components involved in clotting. Although platelet count is not technically part of every liver panel, it can provide useful context.

In chronic liver disease, portal hypertension and an enlarged spleen may contribute to a falling platelet count. Platelet count is also used in noninvasive fibrosis calculations such as FIB-4, which combines age, AST, ALT, and platelets to help estimate the likelihood of advanced liver scarring. NIDDK notes that clinicians may use routine laboratory results to calculate FIB-4 or APRI when assessing fatty liver disease and fibrosis risk.

A low platelet count has many other possible causes, so it should not automatically be attributed to the liver.

Recognizing Liver-Test Patterns

Clinicians often interpret liver markers by grouping them into broad patterns.

Hepatocellular Pattern

A hepatocellular pattern occurs when ALT and AST rise more prominently than ALP. This suggests that the main abnormality involves liver cells rather than bile drainage.

Possible causes include viral hepatitis, metabolic fatty liver disease, autoimmune hepatitis, medication injury, alcohol-related injury, or reduced blood flow. Additional testing is needed to distinguish among them.

Cholestatic Pattern

A cholestatic pattern occurs when ALP rises more prominently, often with GGT and sometimes bilirubin. It suggests impaired bile formation or movement.

Possible explanations include gallstones, bile-duct disease, medication effects, inflammation, or structural obstruction.

Mixed Pattern

Both aminotransferases and cholestatic markers may be substantially elevated. Medication-related injury, infection, obstruction, and several other conditions can create mixed patterns.

Reduced Synthetic Function

Low albumin or prolonged PT/INR may raise concern about reduced protein production, especially when they occur with other evidence of chronic or severe liver disease. Because both markers have non-liver causes, they must be interpreted in context.

These patterns help organize the evaluation; they do not replace diagnosis.

Understanding Common Kidney Lab Markers

Kidney testing asks at least two separate questions:

1. How well are the kidneys filtering the blood?
2. Is there evidence that the kidney tissue or filtering barrier is damaged?

The principal markers used to answer these questions are eGFR and urine albumin. NIDDK identifies them as the two key markers for chronic kidney disease.

Serum Creatinine

Creatinine is a waste product generated largely through normal muscle metabolism. Healthy kidneys remove most circulating creatinine through filtration.

When filtration decreases, serum creatinine often rises. The value is then used in an equation to estimate GFR. Creatinine is useful and widely available, but it is not a perfect stand-alone measurement of kidney function.

Creatinine can be affected by:

• Muscle mass
• Age and body composition
• Amputation or muscle-wasting conditions
• Recent consumption of cooked meat
• Intense exercise
• Certain medicines
• Acute illness
• Hydration and circulation

A relatively low creatinine does not always mean filtration is normal, particularly in someone with very low muscle mass. Conversely, a muscular person may have a higher creatinine without having the same degree of kidney impairment that the number would suggest in another individual.

This is one reason eGFR is reported rather than interpreting serum creatinine by itself.

Estimated Glomerular Filtration Rate: eGFR

The glomerular filtration rate describes how much blood fluid the kidneys filter over time. Because directly measuring GFR is impractical for routine care, laboratories estimate it using a blood marker—usually creatinine—and a validated equation.

eGFR is commonly reported in milliliters per minute per 1.73 square meters of body-surface area. It is an estimate, not a literal percentage of kidney function. KDIGO recommends interpreting eGFR as part of a broader assessment that includes albuminuria, cause of disease, chronicity, and clinical context.

Kidney filtration categories are commonly organized as:

• G1: eGFR of 90 or higher
• G2: eGFR of 60–89
• G3a: eGFR of 45–59
• G3b: eGFR of 30–44
• G4: eGFR of 15–29
• G5: eGFR below 15

G1 and G2 do not establish chronic kidney disease unless another marker of kidney damage is present. A person may have an eGFR above 60 and still have CKD because of persistent albuminuria, structural abnormalities, or another form of kidney damage. Conversely, one unexpectedly low eGFR does not automatically prove chronic disease.

Chronic kidney disease generally requires a qualifying abnormality to persist for at least three months. Repeat testing helps distinguish CKD from acute kidney injury, dehydration, medication-related changes, or normal biological variation.

Cystatin C

Cystatin C is another blood marker that can be used to estimate kidney filtration. It is produced by nucleated cells and is less directly dependent on muscle mass than creatinine.

A clinician may order cystatin C when a creatinine-based eGFR could be misleading or when a more confident filtration estimate would affect an important decision. Current KDIGO guidance supports combining creatinine and cystatin C when cystatin C is available and greater accuracy is needed.

Cystatin C is not completely unaffected by non-kidney factors. Inflammation, thyroid status, corticosteroid use, smoking, and other conditions may influence it. Its value lies in providing a second perspective rather than serving as a flawless measure.

Urine Albumin-to-Creatinine Ratio: UACR

Albumin normally remains in the bloodstream. When the glomerular filtering barrier is damaged, albumin may leak into the urine. This is called albuminuria.

A UACR compares the amount of albumin with the amount of creatinine in a spot urine sample. The ratio helps account for how concentrated or dilute the urine is.

Common albuminuria categories are:

• A1: Less than 30 mg/g—normal to mildly increased
• A2: 30–300 mg/g—moderately increased
• A3: More than 300 mg/g—severely increased

NIDDK states that a UACR of 30 mg/g or less is generally considered normal, while a result above 30 mg/g may indicate kidney disease.

A temporary elevation may occur with fever, infection, strenuous exercise, menstruation, marked hyperglycemia, or uncontrolled blood pressure. An unexpected result is often repeated to determine whether albuminuria is persistent.

UACR and eGFR should not be treated as competing tests. A person can have preserved eGFR with significant albuminuria, or reduced eGFR with little albumin in the urine. Together, the two markers provide a more complete estimate of kidney and cardiovascular risk.

Blood Urea Nitrogen: BUN

Urea is produced when the body breaks down protein. The liver forms urea, and the kidneys remove much of it through urine. A BUN test measures the nitrogen portion of circulating urea.

BUN may rise when kidney filtration decreases, but it is less specific than creatinine. It can also increase with:

• Dehydration or reduced kidney blood flow
• High protein intake
• Gastrointestinal bleeding
• Corticosteroid use
• Fever, infection, or increased tissue breakdown

A low BUN can occur with low protein intake, severe liver dysfunction, pregnancy, or excess body water.

BUN is often most helpful when interpreted with creatinine, eGFR, symptoms, and fluid status rather than as an independent measure of kidney health.

Urinalysis

A urinalysis examines the physical and chemical characteristics of urine. Depending on the test, it may assess:

• Protein
• Blood
• Glucose
• Ketones
• White blood cells
• Nitrites
• Acidity
• Specific gravity
• Bilirubin
• Crystals
• Cells and casts under a microscope

Different patterns suggest different possibilities. White blood cells and nitrites may support a urinary-tract infection. Blood may result from stones, infection, kidney inflammation, bladder disease, menstruation, exercise, or another source. Glucose may appear when blood glucose is high or when kidney-tubule handling is altered.

Urinalysis does not always quantify small amounts of albumin accurately. A dipstick may therefore appear negative even when UACR detects moderately increased albumin leakage. This is why targeted UACR testing remains important for people at risk of chronic kidney disease.

Electrolytes and Bicarbonate

The kidneys help regulate sodium, potassium, chloride, bicarbonate, calcium, phosphorus, and water. These measurements are often included in metabolic panels or ordered separately when kidney disease is suspected or established.

Potassium

Potassium is essential for nerve and muscle activity, including normal heart rhythm. Advanced kidney dysfunction can reduce potassium excretion, but high potassium can also result from medications, uncontrolled diabetes, tissue injury, acid-base problems, or specimen-related cell breakdown.

A falsely high potassium result can occur if blood cells rupture during collection or handling. An unexpected elevation may therefore be repeated promptly.

Markedly high potassium can be dangerous, especially when accompanied by weakness, palpitations, or electrocardiogram changes. Urgent management depends on the level, symptoms, rate of change, and clinical setting.

Bicarbonate

Bicarbonate helps maintain acid-base balance. The kidneys normally remove acids and regenerate bicarbonate.

A low bicarbonate level may occur as kidney function declines, but diarrhea, medications, respiratory disorders, diabetes-related ketoacidosis, and other conditions can also affect it. Persistently low bicarbonate in CKD may indicate metabolic acidosis and may influence treatment.

Calcium and Phosphorus

The kidneys participate in vitamin D activation and phosphorus regulation. As kidney disease becomes more advanced, disturbances in calcium, phosphorus, vitamin D, and parathyroid hormone may develop.

These changes generally require interpretation as a group. A single calcium or phosphorus result does not fully describe bone and mineral health.

Complete Blood Count and Kidney Disease

A complete blood count is not a direct kidney-function test, but it may identify complications or related conditions.

The kidneys produce erythropoietin, a signal that stimulates red-blood-cell production. As chronic kidney disease progresses, reduced erythropoietin production can contribute to anemia. Iron deficiency, inflammation, blood loss, vitamin deficiency, and other conditions may also cause or worsen anemia.

Hemoglobin and hematocrit results therefore need to be interpreted with iron studies, kidney function, symptoms, medication history, and other possible causes.

Why One Abnormal Result May Need to Be Repeated

Laboratory values change for both medical and nonmedical reasons. Repeat testing helps determine whether an abnormality is persistent, worsening, improving, or inconsistent with the rest of the picture.

Factors that may temporarily influence liver or kidney markers include:

• Acute infection or fever
• Vomiting, diarrhea, or dehydration
• Recent strenuous exercise
• Muscle injury
• A new prescription or supplement
• A medication dose change
• Alcohol exposure
• Fasting or major dietary changes
• Menstruation affecting a urine sample
• Problems during specimen collection or handling

A repeat test is not always the correct response. A severe abnormality, rapidly changing result, or concerning symptom may require immediate evaluation rather than waiting.

Why Trends Matter More Than Isolated Numbers

A single result is a snapshot. Several results over time can reveal direction and speed.

Examples include:

• ALT that remains mildly elevated across several months
• ALP and bilirubin rising together
• Albumin gradually falling
• Creatinine increasing after a new medicine
• eGFR declining across repeated measurements
• UACR progressing from mildly to severely increased
• Potassium rising as kidney function worsens

Trends can also show improvement after an acute illness resolves, an obstruction is relieved, alcohol exposure is reduced, metabolic health improves, or a medication is adjusted.

The size of a change should be considered alongside normal biological and laboratory variation. A small shift does not always represent true disease progression, but a consistent direction deserves attention.

When Liver and Kidney Results Overlap

Some laboratory markers involve both organs or may be altered by disease in either system.

Albumin

Low blood albumin may reflect reduced liver production, kidney protein loss, inflammation, malnutrition, gastrointestinal loss, or fluid overload. A UACR or other urine-protein test can help determine whether the kidneys are losing albumin.

BUN

The liver produces urea, while the kidneys remove it. Severe liver dysfunction may lower BUN production, whereas reduced kidney filtration may raise it. Hydration and protein metabolism also influence the result.

Medication Levels and Effects

The liver metabolizes many medicines, and the kidneys eliminate many drugs or their metabolites. Reduced function in either organ can change drug exposure. Laboratory results may therefore affect medicine selection, dose, or monitoring frequency.

Fluid and Electrolyte Changes

Advanced liver disease may cause fluid retention, low blood sodium, and altered kidney circulation. Advanced kidney disease can also cause swelling and electrolyte abnormalities. The broader clinical pattern is needed to determine the main cause.

What a “Normal” Panel Does Not Rule Out

Normal liver enzymes do not guarantee that the liver contains no fat, inflammation, or fibrosis. NIDDK notes that fatty liver evaluation may require clinical history, fibrosis calculations, imaging, and occasionally biopsy rather than relying on aminotransferases alone.

Likewise, a serum creatinine within the printed reference range does not always guarantee normal kidney filtration. The same creatinine value can correspond to different eGFR results depending on age and other factors used in the estimating equation.

A normal eGFR does not rule out kidney damage if albuminuria, blood in the urine, structural abnormalities, or an inherited disease is present. KDIGO therefore classifies chronic kidney disease using cause, eGFR category, and albuminuria category rather than filtration alone.

When Additional Testing May Be Needed

Abnormal screening results may lead to more targeted testing.

For possible liver disease, additional evaluation may include:

• Hepatitis testing
• Iron studies
• Autoimmune antibodies
• Ceruloplasmin or copper-related testing
• Ultrasound
• Elastography
• CT or MRI
• Noninvasive fibrosis calculations
• Liver biopsy in selected cases

For possible kidney disease, additional evaluation may include:

• Repeat creatinine and eGFR
• Cystatin C
• Repeat UACR
• Urine-protein quantification
• Microscopic urinalysis
• Kidney ultrasound
• Immune and infection-related blood tests
• Genetic testing
• Kidney biopsy in selected cases

No single extended panel is appropriate for everyone. The next test should be chosen according to the abnormal pattern, symptoms, age, medications, family history, and level of clinical concern.

Questions to Ask About Your Results

When reviewing a report with a healthcare professional, useful questions include:

• Which result is abnormal, and how far outside the laboratory range is it?
• Does the pattern suggest liver-cell injury, impaired bile flow, reduced filtration, or another problem?
• Could a prescription, over-the-counter medicine, or supplement affect the result?
• Could recent illness, dehydration, exercise, or alcohol exposure have contributed?
• Should the test be repeated, and when?
• Are previous results available for comparison?
• Do I need a UACR as well as an eGFR?
• Is imaging or specialist evaluation appropriate?
• Are any medication doses affected by my liver or kidney results?
• Which symptoms should prompt urgent medical attention?

These questions help shift the conversation from whether a number is simply “high” or “low” to what the overall pattern means.

When to Seek Prompt Medical Care

Arrange timely medical evaluation for:

• Persistent or repeatedly worsening liver-enzyme abnormalities
• A falling eGFR
• Rising creatinine
• Persistent urine albumin or blood
• Elevated bilirubin
• Falling albumin without a clear explanation
• New electrolyte abnormalities
• Abnormal results after starting a medicine or supplement
• New swelling, foamy urine, itching, fatigue, or changes in urination

Seek urgent care for:

• Yellowing of the eyes or skin with worsening illness
• Severe confusion or unusual drowsiness
• Vomiting blood or passing black stools
• Very little or no urine
• Severe shortness of breath or rapidly increasing swelling
• Severe weakness, paralysis, or an abnormal heartbeat
• Intense flank pain with fever
• A rapidly rising creatinine or potassium result reported as critical

Laboratory results should always be considered alongside symptoms. A number that appears only moderately abnormal may still require urgent attention in the right clinical setting.

The Bottom Line

Liver and kidney laboratory markers provide different pieces of information.

ALT and AST mainly reflect liver-cell injury. ALP and GGT help identify patterns involving bile flow. Bilirubin reflects processing and excretion, while albumin and PT/INR can provide information related to protein production. None of these markers is specific enough to diagnose every liver condition alone.

Creatinine and eGFR estimate kidney filtration. UACR looks for albumin leakage and may reveal kidney damage before filtration falls substantially. BUN, urinalysis, electrolytes, bicarbonate, and blood counts provide additional information about causes, complications, and the body’s internal balance.

The goal is not to interpret each result in isolation. The most reliable assessment comes from patterns, trends, risk factors, symptoms, medication history, and appropriate follow-up testing.

References

1. National Institute of Diabetes and Digestive and Kidney Diseases — “Chronic Kidney Disease Tests & Diagnosis.” Guidance on creatinine, eGFR, urine albumin-to-creatinine ratio, repeat testing, and interpretation of kidney markers.
2. Kidney Disease: Improving Global Outcomes — 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. International guidance on eGFR, albuminuria, CKD classification, chronicity, cystatin C, and kidney-risk assessment.
3. MedlinePlus — “Liver Function Tests.” Overview of ALT, AST, ALP, GGT, bilirubin, albumin, total protein, and prothrombin time within common liver panels.
4. National Institute of Diabetes and Digestive and Kidney Diseases — “Diagnosis of Cirrhosis.” Explanation of how liver enzymes, bilirubin, albumin, blood counts, imaging, and other tests contribute to liver evaluation.
5. National Institute of Diabetes and Digestive and Kidney Diseases — “Quick Reference on UACR & GFR.” Clinical reference identifying urine albumin and eGFR as the principal markers used to detect and monitor chronic kidney disease.
6. MedlinePlus — “Prothrombin Time Test and INR.” Explanation of clotting-time measurement, standardized INR reporting, liver production of clotting factors, and medication-related interpretation.